At AGBT, 454, Illumina, ABI Vow to Improve Speed, Yield, Quality of Next-Gen Offerings | GenomeWeb
454/Roche, Illumina, and Applied Biosystems expect the performance specs of their next-generation sequencing systems to improve significantly this year, according to talks by vendors and early-access users of the upgrades at the Advances in Genome Biology and Technology meeting in Marco Island, Fla., this month.
 
Over the next few months, users of all three systems can expect improvements such as longer reads, new paired-end libraries, shortened run times, higher throughput, and better accuracy, resulting from upgrades in the hardware, biochemist

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.